banner
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER)
@icer-review.bsky.social
190 followers 110 following 93 posts
Encouraging fair pricing, fair access, and future innovation within the US health care system | Reposts not endorsements
Posts Media Videos Starter Packs
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · 2d
How to make one line in the FDA Commissioner’s new drug review program into a force for affordable access for patients -- a new Health Affairs Scholar paper by ICER President and CEO Sarah Emond and Chief Scientific Officer Dan Ollendorf: tinyurl.com/32bexcd9
How to make one line in the FDA Commissioner's new drug review program into a force for affordable access for patients
Abstract. The FDA Commissioner's new National Priority Voucher program seeks to accelerate drug approvals for products meeting certain criteria. Interestin
tinyurl.com
1
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · 5d
ICER #WeeklyView: Vaccines for COVID-19 to be assessed, Trump Administration’s drug pricing announcements, & ACA subsidies conta.cc/4nCjZDy
ICER Weekly View: Vaccines for COVID-19 to be assessed, Trump Administration’s drug pricing announcements, & ACA subsidies
Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View October 3, 2025 From the desk of ICER Communications Good
conta.cc
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · 9d
Institute for Clinical and Economic Review to Assess Vaccines for COVID-19: tinyurl.com/2tfn5pme
Institute for Clinical and Economic Review to Assess Vaccines for COVID-19 - ICER
Report will be subject of New England CEPAC meeting in June 2026.
tinyurl.com
1 1
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · 12d
ICER #WeeklyView: NCFB public meeting, GLP-1s lower costs, & pharma responses to new regulations conta.cc/3IIbHe7
ICER Weekly View: NCFB public meeting, GLP-1s lower costs, & pharma responses to new regulations
Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View September 26, 2025 From the desk of ICER Communications G
conta.cc
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · 19d
ICER #WeeklyView: CMS report, GLP-1 cost-effectiveness, & soaring health care costs conta.cc/4mjUh59
ICER Weekly View: CMS report, GLP-1 cost-effectiveness, & soaring health care costs
Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View September 19, 2025 From the desk of ICER Communications G
conta.cc
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · 23d
Institute for Clinical and Economic Review to Undertake Special Report on Crohn’s Disease and Ulcerative Colitis for CMS as Part of Public Comment Process on Medicare Drug Price Negotiations: tinyurl.com/4urn4xf7
Institute for Clinical and Economic Review to Undertake Special Report on Crohn’s Disease and Ulcerative Colitis for CMS as Part of Public Comment Process on Medicare Drug Price Negotiations - ICER
Report to reflect legislative specifications in the Inflation Reduction Act and most recent CMS guidance regarding price negotiations.
tinyurl.com
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · 26d
ICER #WeeklyView: Obesity draft evidence report, NCFB evidence report, & a crackdown on pharma ads conta.cc/46wGALw
ICER Weekly View: Obesity draft evidence report, NCFB evidence report, & a crackdown on pharma ads
Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View September 12, 2025 From the desk of ICER Communications G
conta.cc
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · 29d
Institute for Clinical and Economic Review Releases Draft Evidence Report on Treatments for Obesity: tinyurl.com/4zzsd7dw
Institute for Clinical and Economic Review Releases Draft Evidence Report on Treatments for Obesity - ICER
Public comment period now open until October 6, 2025; Requests to make oral comment during public meeting also being accepted.
tinyurl.com
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · Sep 8
Institute for Clinical and Economic Review Publishes Evidence Report on Treatment for Non-Cystic Fibrosis Bronchiectasis: tinyurl.com/39by2hs5
Institute for Clinical and Economic Review Publishes Evidence Report on Treatment for Non-Cystic Fibrosis Bronchiectasis - ICER
There are significant uncertainties regarding long term efficacy of brensocatib; ICER estimates that treatment would achieve common thresholds of cost-effectiveness if priced between $3,100 and $3,700...
tinyurl.com
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · Sep 5
ICER #WeeklyView: SMA final evidence report, upcoming GLP-1 draft report & prescription drug reforms conta.cc/3V0BdOo
ICER Weekly View: SMA final evidence report, upcoming GLP-1 draft report & prescription drug reforms
Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View September 5, 2025 From the desk of ICER Communications Go
conta.cc
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · Sep 2
Institute for Clinical and Economic Review Publishes Final Evidence Report on Treatments for Spinal Muscular Atrophy: tinyurl.com/mw453b9h
Institute for Clinical and Economic Review Publishes Final Evidence Report on Treatments for Spinal Muscular Atrophy - ICER
Independent appraisal committee votes reflect uncertainty in net health benefit for apitegromab and for add-on treatments after gene therapy.
tinyurl.com
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · Aug 22
ICER #WeeklyView: A note from ICER’s CEO, rising employer health costs, & direct-to-consumer pricing conta.cc/4mV72nD
ICER Weekly View: A note from ICER’s CEO, rising employer health costs, & direct-to-consumer pricing
Email from ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View August 22, 2025 From the desk of ICER Communications Good morning, everyone. Today we start things o
conta.cc
1
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · Aug 18
The Health Economics Methods Advisory (HEMA) has a new website! hemamethods.org

HEMA was convened by leaders at 3 global HTA organizations: ICER, @nicecomms.bsky.social, and @cda-amc.bsky.social
to critically and independently examine and assess new methods and processes.
Health Economics Methods Advisory
hemamethods.org
3 5
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · Aug 18
The first HEMA Draft Report will be published on September 24th, which will be open to public comment until October 15th.

Mark your calendars and submit your public comments via [email protected]!

Learn more: hemamethods.org
Health Economics Methods Advisory
hemamethods.org
1 1
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · Aug 15
ICER #WeeklyView: reflections on new GLP-1 research, an NCFB approval, & the impact of rising premiums conta.cc/3UtEllG
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · Aug 8
ICER #WeeklyView: ICER’s Patient Council, RFK Jr. cancels $500M mRNA vaccine contracts, & CMMI to experiment with weight loss Rx coverage: conta.cc/451WXiC
Reposted by Institute for Clinical and Economic Review (ICER)
dano-hta.bsky.social
Dan Ollendorf @dano-hta.bsky.social · Aug 4
New @healthaffairs.bsky.social paper on how CMS can integrate formal aspects of #HTA, much of which is patterned after @icer-review.bsky.social practices! Many thanks to @commonwealthfund.org for their support. @basucally.bsky.social @leah-rand.bsky.social
www.healthaffairs.org/doi/10.1377/...
Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price Negotiations | Health Affairs Journal
The Centers for Medicare and Medicaid Services (CMS) can now negotiate the prices of a set of drugs that represent significant Medicare expenditures. The long-term success of negotiations will depend ...
www.healthaffairs.org
5 8
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · Aug 1
TODAY -- at 11 AM ET join us for the virtual public meeting on the comparative clinical effectiveness and value of several treatments for spinal muscular atrophy (SMA).

Register here: events.zoom.us/ev/AoeC1QxiP...
Midwest CEPAC August 2025 Public Meeting on Spinal Muscular Atrophy
events.zoom.us
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · Aug 1
ICER #WeeklyView: Today’s SMA public meeting, more on MFN, & the Sarepta controversy continues conta.cc/3UC8zmm
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · Jul 31
Institute for Clinical and Economic Review to Assess Therapies for IgA Nephropathy: tinyurl.com/3z3pv8rz
Institute for Clinical and Economic Review to Assess Therapies for IgA Nephropathy - ICER
Report will be subject of CTAF meeting in February 2026; Draft Scoping Document open to public comment until August 20, 2025.
tinyurl.com
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · Jul 30
This Friday -- at 11 AM ET join us for the virtual public meeting on the comparative clinical effectiveness and value of several treatments for spinal muscular atrophy (SMA).

Register here: events.zoom.us/ev/AoeC1QxiP...
Midwest CEPAC August 2025 Public Meeting on Spinal Muscular Atrophy
events.zoom.us
1
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · Jul 25
ICER #WeeklyView: NCFB Draft Evidence Report, Sarepta vs FDA, & Makary’s new voucher program conta.cc/41aqUKX
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · Jul 23
Institute for Clinical and Economic Review Releases Draft Evidence Report on Treatment for Non-Cystic Fibrosis Bronchiectasis: tinyurl.com/y65ncwez
Institute for Clinical and Economic Review Releases Draft Evidence Report on Treatment for Non-Cystic Fibrosis Bronchiectasis - ICER
Public comment period now open until August 19, 2025; Requests to make oral comment during public meeting also being accepted.
tinyurl.com
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · Jul 18
ICER #WeeklyView: A “Prescription for Better Access” episode, SMA Evidence Report, & Final MS Report conta.cc/3IPogE0
icer-review.bsky.social
Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · Jul 17
Institute for Clinical and Economic Review Publishes Evidence Report on Treatments for Spinal Muscular Atrophy: icer.org/news-insight...
3